Article Details

Connect BioPharma Successfully Completes CBP-174 Phase 1 - GlobeNewswire

Retrieved on: 2022-08-30 12:04:27

Tags for this article:

Click the tags to see associated articles and topics

Connect BioPharma Successfully Completes CBP-174 Phase 1 - GlobeNewswire. View article details on hiswai:

Excerpt

SAN DIEGO and TAICANG, SUZHOU, China, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up